524520

- KMC Speciality Hospitals (India) Limited held its 43rd Annual General Meeting (AGM) on September 28, 2026. - All five resolutions, including the adoption of financial statements, re-appointment of Dr. S. Vijayabaskaran as director, material related party transactions, ratification of cost auditor remuneration, and borrowing limits, were passed with the requisite majority.

- KMC Speciality Hospitals (India) Limited held its 43rd Annual General Meeting (AGM) on September 28, 2026, through video conferencing. - Shareholders considered and adopted the audited financial statements for the financial year ended March 31, 2026. - Dr. S. Vijayabaskaran was re-appointed as a director retiring by rotation. - Approval was granted for material related party transactions with the holding company, Sri Kauvery Medical Care (India) Limited, and the remuneration of the cost auditor for FY 2026-27 was ratified. - Special resolution regarding borrowing limits under Section 180(1)(c) and 180(1)(a) of the Companies Act, 2013 was also transacted.

- The filing addresses and rectifies discrepancies in previous disclosures under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as requested by BSE on September 4, 2026. - Sri Kauvery Medical Care (India) Limited (SKMCIL), the promoter, created an indirect encumbrance over its own shares, not directly over KMC Speciality Hospitals (India) Ltd. - This includes a pledge of 74,10,831 equity shares (14.53% of SKMCIL's fully diluted shareholding) and a Non-Disposal Undertaking over 1,65,32,316 equity shares (32.40% of SKMCIL's fully diluted shareholding). - The encumbrance, completed on August 4, 2026, is in favour of Catalyst Trusteeship Limited (Debenture Trustee) as security for credit facilities availed by the promoter group.

- Promoter (Sri Kauvery Medical Care) increased indirect share encumbrance in KMC Specialty Hospitals (Target Company). - 27,41,435 SKMCIL shares (5.37% fully diluted) were pledged to secure debentures and a credit facility. - This raised the promoter's total encumbered shares in the Target Company from 14.53% to 19.90%.

- Submission of Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per SEBI LODR Regulation 34(2)(f). - Highlights include increased renewable energy consumption to 92%, 'Great Place to Work' certification, and LEED Silver rating for Maa Kauvery Unit. - The report details the company's ESG performance and commitments.

- Investor Presentation for KMC Speciality Hospitals (India) Limited for the quarter ended 30th June, 2026 (Q1 FY2027).

- Approval for new capacity expansion projects. Trichy Campus to add ~500 beds for Rs. 486 Cr (Q4 FY28, Q2 FY30). Bengaluru Mother & Child Hospital to add ~91 beds for Rs. 33 Cr (Q2 FY28). M/s. G Sugumar & Co appointed as Cost Auditor for FY 2026-27.

- Q1 FY27 Standalone Revenue ₹91.78Cr vs ₹66.55Cr (▲38% YoY) - EBITDA ₹28.49Cr vs ₹16.45Cr (▲73% YoY) - PAT ₹16.57Cr vs ₹7.54Cr (▲120% YoY) - EBITDA Margin 31.04% vs 24.72% (▲632bps)

- Q1 FY27 Standalone Revenue ₹91.78 Cr vs ₹66.55 Cr (▲37.9% YoY) - EBITDA ₹30.29 Cr vs ₹17.25 Cr (▲75.6% YoY) - PAT ₹16.57 Cr vs ₹7.54 Cr (▲120.1% YoY) - EBITDA Margin 33.0% vs 25.9% (▲708bps)

- Catalyst Trusteeship disclosed encumbrance on 46.93% of Sri Kauvery Medical Limited (SKMCIL) shares by promoters, comprising a 14.53% pledge and a 32.40% non-disposal undertaking. This secures debentures issued by Prospera Healthcorp Private Limited. SKMCIL holds 75% of KMC Speciality Hospitals.

- Board Meeting scheduled for Friday, 14th August, 2026. - To consider and approve unaudited financial results for the quarter ended 30th June, 2026.

- Promoter Sri Kauvery Medical Care (India) Limited (SKMCIL) disclosed indirect encumbrance on its shares, which hold 75% of KMC Speciality Hospitals (India) Limited. - This encumbrance (pledge and non-disposal undertaking) totals ~46.93% of SKMCIL's shares. - It secures Non-Convertible Debentures issued by Prospera Healthcorp Private Limited.

- Trading window for Designated Persons is closed from July 1, 2026. - It will remain closed until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. - This is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.